Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9025430 | 1.00 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9405322 | 1.00 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL8886962 | 1.00 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL22030553 | 1.00 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL14101252 | 1.00 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL8649977 | 0.97 | GAA (0.32) | CYP2C9MAPTMEN1KMT2A | |
| SCHEMBL4567642 | 0.97 | GAA (0.32) | CYP2C9MAPTMEN1KMT2A | |
| SCHEMBL26186218 | 0.97 | GAA (0.32) | CYP2C9MAPTMEN1KMT2A | |
| SCHEMBL19722230 | 0.94 | CYP2C9 (0.31) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL15495042 | 0.93 | CYP2C9 (0.33) | CYP2C9ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6206837-A | — | — | None | — | — | JP | disclosed |
| US-20260062616-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL OPTICAL ELEMENT CONTAINING SAME | NANCHANG VIRTUAL REALITY RES INSTITUTE CO LTD (CN) | 2026-03-05 | — | — | US | disclosed |
| US-12493220-B2 | Optical dimming devices with chiral ferroelectric nematic liquid crystal | META PLATFORMS TECHNOLOGIES, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4584632-A1 | OPTICAL DIMMING DEVICES WITH CHIRAL FERROELECTRIC NEMATIC LIQUID CRYSTAL | Meta Platforms Technologies, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20240094584-A1 | OPTICAL DIMMING DEVICES WITH CHIRAL FERROELECTRIC NEMATIC LIQUID CRYSTAL | META PLATFORMS TECHNOLOGIES, LLC | 2024-03-21 | — | — | US | disclosed |
| WO-2024054496-A1 | OPTICAL DIMMING DEVICES WITH CHIRAL FERROELECTRIC NEMATIC LIQUID CRYSTAL | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20240067879-A1 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-11802243-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2023-10-31 | — | — | US | disclosed |
| US-11795398-B2 | Liquid-crystalline medium and liquid-crystal display comprising the same and compounds | MERCK PATENT GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-7211302-B2 | Photostable liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-05-01 | — | — | US | disclosed |
| US-20070080324-A1 | mixture of polar compounds of negative dielectric anisotropy; electro-optical display with active-matrix addressing based on the ECB(electrically controlled birefringence), PALC (positive charge assisted leakage current) or IPS ( in plane switching) effect | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1762605-A1 | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | Chisso Petrochemial Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-7189440-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-03-13 | — | — | US | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070018136-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-01-25 | — | — | US | disclosed |
| US-20070012898-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-01-18 | — | — | US | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| JP-H06206837-A | CHIRAL 2,6-DIFLUOROBENZENE DERIVATIVE | MERCK PATENT GMBH | 1994-07-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | LEF1, CFD, FOXO1 | CYP2C9 3113/4885ALDH1A1 2679/4885LMNA 941/4885 |
| US-20260062616-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL OPTICAL ELEMENT CONTAINING SAME | CRY1, CRY2, CCNE2 | CYP2C9 1198/4885ALDH1A1 3809/4885LMNA 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.